THANKS for a crystal clear post about the BLA proc
Post# of 144932
Once Leronlimab makes it through the BLA gauntlet (and they will), the chances of successful approval are 86%.*
Leronlimab's chances are equal to that and probably better. It's only a matter of time.
*Clinical Development Success Rates 2006-2015" @ bio.org
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)